PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease ReportsNausea
MeSH D009325 - nausea
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012817:Digestive signs and symptoms
0 Companies
0 Drugs
Success rate
D009325: 
Nausea
D020250:Postoperative nausea and vomiting
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
A.H. Robins CompanyDiphenhydramine Diphenhydramine  1982-01-01   
Abbott BiotherapeuticsChlorpromazine Chlorpromazine  1982-01-01   
Promethazine Promethazine  1982-01-01   
AbbVieDexamethasone Ozurdex 2023-01-09 2009-06-17 $492 M Q4/23-Q3/24 
Able LaboratoriesHydroxyzine Hydroxyzine  2004-07-22   
Prochlorperazine Prochlorperazine  2001-07-11   
Promethazine Promethazine  2003-02-27   
Accord HealthcarePalonosetron Palonosetron Accord  2016-05-26   
Ajanta PharmaProchlorperazine Prochlorperazine  2024-05-09   
Alcon ResearchDexamethasone Maxidex  1982-01-01   
Dexamethasone, Neomycin, Polymyxin b Neomycin Polymyxin B Sulfates Dexamethasone  1986-11-17   
Dexamethasone, Neomycin Neomycin Sulfate-dexamethasone  1986-07-21   
Alembic PharmaceuticalsChlorpromazine Chlorpromazine  2023-07-18   
Alkem LaboratoriesDronabinol Marinol  1985-05-31   
AllerganDexamethasone Aeroseb-dex  1982-01-01   
Chlorpromazine Chlorpromazine  1982-01-01   
Dexamethasone Dexamethasone  1982-01-01   
Dimenhydrinate Dimenhydrinate  1982-01-01   
Diphenhydramine Diphenhydramine  1982-01-01   
Hydroxyzine Hydroxyzine  1994-03-18   
Hydroxyzine Hydroxyzine Pamoate  1991-07-31   
Perphenazine Perphenazine  2016-10-17   
Amitriptyline, Perphenazine Perphenazine Amitriptyline  1986-08-25   
Prochlorperazine Prochlorperazine  1982-01-01   
Promethazine Prometh  1982-01-01   
Promethazine Promethazine  2003-06-24   
Codeine, Promethazine Promethazine Codeine  1984-10-31   
Trimethobenzamide Trimethobenzamide  1982-10-19   
1
2
3
4
5
6
...
15
>
Clinical Trials
Historical Success Rate
Phase 1
46%
11/24
Phase 2
51%
20/39
Phase 3
93%
50/54
Approved: 23Overall Success rate: 22%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
AbbVie
Allergan
1
2
3
4
5
6
...
10
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use